Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 5, 2017

Primary Completion Date

June 28, 2018

Study Completion Date

June 28, 2018

Conditions
Sickle Cell Disease
Trial Locations (2)

38105

St. Jude Children's Research Hospital, Memphis

38120

Baptist Memorial Hospital, Baptist Clinical Research Institute, Memphis

All Listed Sponsors
collaborator

University of Memphis

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT03344900 - Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth | Biotech Hunter | Biotech Hunter